Researcher
Laurent Rénia earned his PhD degree in 1991 from the University Pierre et Marie Curie (now Sorbonne University) in Paris, France, and completed his postdoctoral work at New York University (1991-1992). He returned to Paris in 1993 as a junior research scientist at the French National Institute of Health (INSERM) and later started his own group at the Institut Cochin in 1997. From 2001 to 2006, he served as Research Director at INSERM and led the Department of Immunology at the Institut Cochin.
In 2007, he joined the A*STAR Singapore Immunology Network (A*STAR SIgN), where he was Executive Director from 2013 to 2020, before becoming the founding Executive Director of the A*STAR Infectious Diseases Labs (A*STAR IDL, 2020-2021). Currently, he is a Professor of Infectious Diseases and Director of the Respiratory and Infectious Diseases Program at Lee Kong Chian School of Medicine, Nanyang Technological University (NTU), as well as a Professor in NTU’s School of Biological Sciences, and a Senior Fellow and Principal Investigator at A*STAR IDL. He also holds an adjunct position at INSERM and has published over 440 articles and book chapters. Additionally, he serves as an academic editor for several journals, including Infection and Immunity and Frontiers in Immunology.
Related Articles
Battling the blaze of malarial infection
10 Sep 2026A*STAR researchers discover a new vaccine target for malaria that could offer more durable protection.
Reinforcing frontline defences against variants
14 Nov 2024Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the
Mixed shots hit a moving target
19 Jan 2024While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals,
Shielding seniors from a crowned killer
8 Dec 2023A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the
Spotting the mechanisms of COVID-19 organ damage
4 Jul 2023A novel tissue-profiling approach provides new insights into the mechanisms of fatal COVID-19 by analysing
Putting vaccine booster alternatives to the test
24 May 2023Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to



